Brief: Viracta Therapeutics Announces Presentation Of Updated Phase 2 Data At Ash 2020 And Productive Outcome Of Its Recent End Of Phase 2 Meeting With FDA

Viracta Therapeutics

07/12/2020 13:46

Dec 7 (Reuters) - Sunesis Pharmaceuticals Inc  SNSS.O :
    * VIRACTA THERAPEUTICS ANNOUNCES PRESENTATION OF UPDATED
PHASE 2
DATA AT ASH 2020 AND PRODUCTIVE OUTCOME OF ITS RECENT END OF
PHASE 2 MEETING WITH FDA
    * VIRACTA THERAPEUTICS - REGISTRATION TRIAL FOR TREATMENT OF
RELAPSED/REFRACTORY EBV+ LYMPHOMAS TO BEGIN IN 1H2021

Source text for Eikon:  ID:nPn2rFkNja 
Further company coverage:  SNSS.O 

 ((Reuters.Briefs@thomsonreuters.com;))